More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
HempMeds® Participates In New York Cannabis World Congress & Business Expo

HempMeds® Participates In New York Cannabis World Congress & Business Expo

by adminAdrianRamirez | Jun 12, 2015 | Company News, HempMeds, Kannakick, Kannalife Sciences, Press Releases

“Low THC Cannabis” Retail Products Showcased in New York by Hemp Industry Innovator San Diego, CA – June 3, 2015 – The entrepreneurial spirit is thriving in New York. As the state prepares for medical cannabis availability, cultivation and dispensary licenses are...
AXIM Biotech Announces Hemp Innovations for Life Sciences

AXIM Biotech Announces Hemp Innovations for Life Sciences

by adminAdrianRamirez | Jun 4, 2015 | Axim Biotechnologies, Company News, Press Releases

Global Industrial Hemp Bioscience Company Announces Entry Into Food and Pharmaceutical Markets SAN DIEGO, June 4, 2015 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and...
RSHO™ Receives Shelf Stability Approval By Denver Public Health Department

RSHO™ Receives Shelf Stability Approval By Denver Public Health Department

by adminAdrianRamirez | Jun 4, 2015 | Company News, HempMeds, Press Releases

Medical Marijuana, Inc.’s HempMeds’ RSHO Receives Shelf Stability Approval By Denver Public Health Department HempMeds’ Flagship Product, Real Scientific Hemp Oil™ (RSHO™) Qualifies for “Potentially Non-Hazardous Food” Handling San Diego, CA – June 3, 2015 –...
Patent For World’s First Cannabinoid Release Gum Awarded to Medical Marijuana, Inc.’s Joint Venture Partner – CanChew Biotechnologies, LLC

Patent For World’s First Cannabinoid Release Gum Awarded to Medical Marijuana, Inc.’s Joint Venture Partner – CanChew Biotechnologies, LLC

by adminAdrianRamirez | May 27, 2015 | Axim Biotechnologies, Company News, Press Releases

One Innovative Cannabinoid Release Gum, Two R&D Markets: Consumer & Pharmaceutical SAN DIEGO, May 27, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is proud to announce that its joint...
AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon

AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon

by adminAdrianRamirez | May 26, 2015 | Axim Biotechnologies, Company News, Press Releases

Industrial Hemp Biosciences Leader Recognized for Service Through Generous Donations of Award-Winning Hemp-Infused Chewing Gum Donation to U.S. Service Members AXIM Biotechnologies, Inc. (AXIM), a leader in industrial hemp biosciences, is proud to announce that the...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.